SE9800016D0 - Antimykotikum, förening därför, förfarande för framställning av den och metod för användning av den - Google Patents

Antimykotikum, förening därför, förfarande för framställning av den och metod för användning av den

Info

Publication number
SE9800016D0
SE9800016D0 SE9800016A SE9800016A SE9800016D0 SE 9800016 D0 SE9800016 D0 SE 9800016D0 SE 9800016 A SE9800016 A SE 9800016A SE 9800016 A SE9800016 A SE 9800016A SE 9800016 D0 SE9800016 D0 SE 9800016D0
Authority
SE
Sweden
Prior art keywords
pct
antimycotic
preparation
imidazolylacetonitrile
dithiolan
Prior art date
Application number
SE9800016A
Other languages
English (en)
Other versions
SE9800016L (sv
Inventor
Niroki Kodama
Yoshimi Niwano
Kazuo Kanai
Masanori Yoshida
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of SE9800016D0 publication Critical patent/SE9800016D0/sv
Publication of SE9800016L publication Critical patent/SE9800016L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9800016A 1995-07-08 1998-01-07 Antimykotikum, förening därför, förfarande för framställning av den och metod för användning av den SE9800016L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19617495 1995-07-08
PCT/JP1996/001872 WO1997002821A2 (en) 1995-07-08 1996-07-05 Antifungal agent, compound therefor, process for producing the same

Publications (2)

Publication Number Publication Date
SE9800016D0 true SE9800016D0 (sv) 1998-01-07
SE9800016L SE9800016L (sv) 1998-01-07

Family

ID=16353435

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9800016A SE9800016L (sv) 1995-07-08 1998-01-07 Antimykotikum, förening därför, förfarande för framställning av den och metod för användning av den

Country Status (22)

Country Link
US (1) US5900488A (sv)
EP (1) EP0839035B1 (sv)
KR (1) KR100386491B1 (sv)
CN (1) CN1091596C (sv)
AT (1) AT407832B (sv)
CA (1) CA2226214C (sv)
CH (1) CH692045A5 (sv)
DE (1) DE19681478B4 (sv)
DK (1) DK176599B1 (sv)
ES (1) ES2137888B1 (sv)
FI (1) FI119357B (sv)
GB (1) GB2317615B (sv)
HK (1) HK1009751A1 (sv)
IL (1) IL122618A (sv)
IN (1) IN185384B (sv)
LU (1) LU90190B1 (sv)
NO (1) NO980055L (sv)
NZ (1) NZ311796A (sv)
SE (1) SE9800016L (sv)
TW (1) TW450969B (sv)
WO (1) WO1997002821A2 (sv)
ZA (1) ZA965745B (sv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127397A (en) * 1996-12-10 2000-10-03 Nihon Nohyaku Co., Ltd. Optically active (R)-(E)-(4-substituted-phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylaceto nitrile derivative, antifungal composition comprising the same, and method for producing the same
AU2003242235A1 (en) * 2002-06-18 2003-12-31 Pola Chemical Industries Inc. Antifungal medicinal composition
EP1537868B1 (en) * 2002-06-18 2011-08-24 Pola Pharma Inc. Antifungal medicinal compositions
EP2005959B1 (en) * 2006-03-08 2015-01-21 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
JP5160409B2 (ja) * 2006-03-08 2013-03-13 日本農薬株式会社 外用の医薬組成物
MX2008011433A (es) 2006-03-08 2008-09-18 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
JP5313905B2 (ja) * 2007-08-27 2013-10-09 日本農薬株式会社 真菌性皮膚炎用剤
WO2009031643A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌組成物
PL2191828T3 (pl) 2007-09-05 2017-02-28 Pola Pharma Inc. Przeciwgrzybicza kompozycja farmaceutyczna
CN101808637B (zh) * 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
CN102395274B (zh) * 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2010117091A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101754697B1 (ko) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 항진균성 약제학적 조성물
US8962669B2 (en) 2010-06-11 2015-02-24 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
WO2014041708A1 (en) * 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
IN2015DN02929A (sv) * 2012-09-14 2015-09-18 Pola Pharma Inc
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
CN104619704B (zh) * 2012-09-14 2017-12-05 宝丽制药股份有限公司 表面自由能用于分化评价晶体的用途，基于表面自由能作为指标评价的晶体，以及通过包含所述晶体制备的药物组合物
US20150352078A1 (en) * 2013-01-28 2015-12-10 Pola Pharma Inc. Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida
EP2948145A1 (en) * 2013-01-28 2015-12-02 Pola Pharma Inc. Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
WO2015162271A1 (en) * 2014-04-25 2015-10-29 Syngenta Participations Ag Microbiocidal imidazole derivatives
WO2016092478A1 (en) 2014-12-12 2016-06-16 Glenmark Pharmaceuticals Limited Process for preparation of luliconazole
WO2017108972A1 (en) 2015-12-21 2017-06-29 Laboratorios Lesvi, S.L. Compounds of r-(-)-(e)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1 -imidazolylacetonitrile-ha (luliconazole-ha) as antifungals
CN106008166B (zh) * 2016-05-17 2018-09-25 上海福乐医药科技有限公司 一种手性2-氯-1-(2,4-二氯苯基)乙醇的工业化生产方法
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
US10898470B1 (en) 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
WO2023131969A1 (en) * 2022-01-09 2023-07-13 Kimia Biosciences Limited Improved process for the preparation of luliconazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218736B1 (en) * 1985-10-10 1993-04-07 Nihon Nohyaku Co., Ltd. A ketene s,s-acetal derivative, a process for manufacturing thereof and a method for curing mycosis by administering it
DE3587252T2 (de) * 1985-10-09 1993-07-15 Nihon Nohyaku Co Ltd Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate.
JP3030780B2 (ja) * 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH0386337A (ja) * 1989-08-28 1991-04-11 Maeda Seisakusho:Kk エクスパンディングチャックを用いた多重巻締め機および多重巻締め方法
CN1038247C (zh) * 1990-05-16 1998-05-06 云南省建筑材料科学研究设计院 一种新型磷石膏胶结料
JP3038519B2 (ja) * 1992-01-28 2000-05-08 日本農薬株式会社 創傷治癒促進剤

Also Published As

Publication number Publication date
LU90190B1 (de) 1998-03-02
NO980055D0 (no) 1998-01-06
FI980023A0 (sv) 1998-01-07
IN185384B (sv) 2001-01-13
AT407832B (de) 2001-06-25
NZ311796A (en) 1999-06-29
ZA965745B (en) 1997-01-27
CN1194582A (zh) 1998-09-30
IL122618A0 (en) 1998-08-16
DE19681478B4 (de) 2006-09-21
WO1997002821A2 (en) 1997-01-30
DE19681478T1 (de) 1998-07-02
EP0839035B1 (en) 2002-10-02
IL122618A (en) 2002-07-25
AU697571B2 (en) 1998-10-08
KR100386491B1 (ko) 2003-08-21
GB2317615A (en) 1998-04-01
SE9800016L (sv) 1998-01-07
CA2226214C (en) 2007-04-17
GB9726766D0 (en) 1998-02-18
CH692045A5 (de) 2002-01-15
KR19990028772A (ko) 1999-04-15
ES2137888A1 (es) 1999-12-16
EP0839035A2 (en) 1998-05-06
CA2226214A1 (en) 1997-01-30
US5900488A (en) 1999-05-04
FI980023A (sv) 1998-01-07
WO1997002821A3 (en) 1997-02-20
ES2137888B1 (es) 2001-01-01
ATA906196A (de) 2000-11-15
NO980055L (no) 1998-03-06
CN1091596C (zh) 2002-10-02
DK1398A (da) 1998-01-07
FI119357B (sv) 2008-10-31
GB2317615B (en) 1998-09-02
HK1009751A1 (en) 1999-06-11
AU6319296A (en) 1997-02-10
TW450969B (en) 2001-08-21
MX9710401A (es) 1998-07-31
DK176599B1 (da) 2008-10-27

Similar Documents

Publication Publication Date Title
SE9800016L (sv) Antimykotikum, förening därför, förfarande för framställning av den och metod för användning av den
DE69723869D1 (de) Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
EP1419773A3 (en) 4-Phenylpiperidine derivatives as modulators of dopamine neurotransmission
DK0808318T3 (da) Tricykliske, substituerede hexahydrobenz[e]isoindol-alfa-1-adrenerge antagonister
LU91554I2 (fr) "Brinzolamide et timolol optionnellement sous forme de sels pharmaceutiquement acceptables tel que la combination du produit brinzolamide/timolol maléate (AZARGA)"
EP1428822A3 (en) 1-phenylpiperazine derivative as modulators of dopamine neurotransmission
IL115920A0 (en) 2,2-dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these
ES2159721T3 (es) Antagonistas alfa-1-adrenergicos biciclicos sustituidos de hexahidrobenz(e)isoindol.
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
ATE200423T1 (de) Verwendung von 1-(2-naphtylethyl)-4-(3- trifluoromethylphenyl)-1,2,3,6-tetrahydropyridi zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode
DE69706382D1 (de) Verfahren zur herstellung von 2,2'-bipyrrolyl-pyrromethen-derivaten (prodigiosine)
DE3686979D1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
IS2274B (is) Aðferð til að búa til kamptóþesín afleiður
DE69819166D1 (de) 8-substituierte-9h-1,3-dioxolo/4,5-h//2,3/benzodiazepin derivate als ampa/kainate-rezeptor-hemmer
DK0823909T3 (da) Hidtil ukendte heterocykliske forbindelser
HK1015283A1 (en) Montirelin for inhibiting sleep apnea
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
ATE237621T1 (de) Herstellung von einem kristallinen amoxicillinsalz
TNSN98190A1 (fr) Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
ATE232859T1 (de) Benzofuranderivate, verfahren zu ihrer herstellung, ihre anwendung als medikament und sie enthaltende pharmazeutische zubereitungen
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
EE05178B1 (et) 1,3-dioksolaanid, nende saamine ja kasutamine k”havastaste ravimite valmistamiseks ning neid sisaldavad farmatseutilised kompositsioonid
HUP0201181A2 (hu) 1,5-Benzodiazepin-származék előállítása és az ezt tartalmazó gyógyszerkészítmény

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9800016-9

Format of ref document f/p: F